CN100532378C - Photosensitive luminescent europium complex and its photosensitive ligand molecule and their synthesis method - Google Patents
Photosensitive luminescent europium complex and its photosensitive ligand molecule and their synthesis method Download PDFInfo
- Publication number
- CN100532378C CN100532378C CNB2007101189788A CN200710118978A CN100532378C CN 100532378 C CN100532378 C CN 100532378C CN B2007101189788 A CNB2007101189788 A CN B2007101189788A CN 200710118978 A CN200710118978 A CN 200710118978A CN 100532378 C CN100532378 C CN 100532378C
- Authority
- CN
- China
- Prior art keywords
- formula
- methyl
- complex
- photosensitive
- europium complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
技术领域 technical field
本发明涉及光敏发光铕配合物及其光敏配体分子与它们的合成方法。The invention relates to photosensitive luminescent europium complexes, photosensitive ligand molecules and their synthesis methods.
背景技术 Background technique
稀土离子的独特电子结构,特别是其5P66S2电子对4f轨道的屏蔽作用,使其化合物具有许多特殊的光谱性质。它们在发光器件(节能灯,发光二极管,显示器)、光纤、光学放大器、激光、生物传感、生物成像及荧光免疫分析等方面具有重要应用价值。稀土离子在可见或近红外区的锐线发射及较长的发光态寿命(ms级)可以减少生物材料本身产生的荧光干扰,使检测具有很高的灵敏度和效率,同时避免了使用放射性元素带来的一系列问题。The unique electronic structure of rare earth ions, especially the shielding effect of its 5P66S2 electrons on the 4f orbital, makes its compounds have many special spectral properties. They have important application value in light-emitting devices (energy-saving lamps, light-emitting diodes, displays), optical fibers, optical amplifiers, lasers, biosensing, bioimaging, and fluorescent immunoassays. The sharp line emission of rare earth ions in the visible or near-infrared region and the long luminescent state lifetime (ms level) can reduce the fluorescence interference generated by the biological material itself, so that the detection has high sensitivity and efficiency, and at the same time avoids the use of radioactive element bands. A series of questions to come.
由于稀土离子的f-f跃迁受电偶极选率的限制,稀土离子本身的光吸收能力很弱,摩尔消光系数很小,因此要获得较好的发光性能,需要对稀土离子进行敏化,即通过作为敏化剂的配体(或电荷转移态)吸光,并使能量转移至稀土离子发光态以实现稀土离子的高效发光。虽然许多稀土配合物能被紫外光激发,获得较好的发光性能,但是紫外光对生物体损伤及干扰较大,也会产生较强的背景荧光,因此向长波方向扩展稀土配合物的激发窗口并提高其在长波光激发下的荧光量子产率成为重要研究方向之一(K.Kuningas,et al.,Anal.Chem.2005,77,7348)。Since the f-f transition of rare earth ions is limited by the electric dipole selection rate, the light absorption ability of rare earth ions itself is very weak, and the molar extinction coefficient is very small. Therefore, to obtain better luminescence performance, rare earth ions need to be sensitized, that is, by The ligand (or charge transfer state) as a sensitizer absorbs light and transfers the energy to the light emitting state of rare earth ions to achieve high-efficiency light emission of rare earth ions. Although many rare earth complexes can be excited by ultraviolet light to obtain better luminescent properties, ultraviolet light can cause greater damage and interference to organisms, and will also produce strong background fluorescence. Therefore, the excitation window of rare earth complexes is extended to the long-wave direction. And improving its fluorescence quantum yield under long-wave light excitation has become one of the important research directions (K. Kuningas, et al., Anal. Chem. 2005, 77, 7348).
WO专利WO2003076938-A报道了的含有三联吡啶和二吡唑—吡啶结构的两类稀土离子敏化分子。其中以N,N,N′,N′-[(4′-(5″′-氨基-2″′-噻吩基)-2,2′:6′,2"-三联吡啶-6,6"-二基)二(亚甲基腈基)]乙酸(N,N,N′,N′-[(4′-(5″′-amino-2″′-thienyl)-2,2′:6′,2"-terpyridine-6,6"-diyl)bis(methylenenitrilo)]tetrakis(acetate))作为敏化配体的Eu3+配合物的激发谱的峰值出现在336nm处,激发窗口尾部延伸到410nm,荧光量子产率为0.15。WO patent WO2003076938-A reports two types of rare earth ion sensitizing molecules containing terpyridine and bipyrazole-pyridine structures. Wherein N, N, N', N'-[(4'-(5"'-amino-2"'-thienyl)-2,2':6',2"-terpyridine-6,6" -diyl)bis(methylenenitrile)]acetic acid (N,N,N',N'-[(4'-(5"'-amino-2"'-thienyl)-2,2':6 ',2"-terpyridine-6,6"-diyl)bis(methylenenitrilo)]tetrakis(acetate)) as a sensitizing ligand, the peak of the excitation spectrum of the Eu 3+ complex appears at 336 nm, and the tail of the excitation window extends to 410nm, the fluorescence quantum yield is 0.15.
Michler酮敏化的Eu(Fod)3(Fod=6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-3,5-octanedionato)配合物体系的激发窗口可以扩展到450nm以上,然而即使在脱氧的条件下,其荧光量子产率也仅为0.2(M.H.V.Werts,et al.,Chem.Commun.1999,799-800).The excitation window of the Michler ketone-sensitized Eu(Fod) 3 (Fod=6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-3,5-octanedionato) complex system can be extended to Above 450nm, however, even under deoxygenated conditions, its fluorescence quantum yield is only 0.2 (MHVWerts, et al., Chem.Commun.1999, 799-800).
本发明的发明人曾经报道了一种稀土配合物[Eu(tta)3dpbt](dpbt如结构式II所示,tta为噻吩甲酰三氟丙酮负离子)。溶解于甲苯中的该配合物(浓度为10-5M的稀溶液)的激发窗口可扩展至441nm,该配合物具有很高的发光量子产率(0.52)(Y.Wang,etal.,Angew.Chem.Int.Ed.2004,43,5010)。[Eu(tta)3dpbt]同时具有很好的双光子敏化发光性能,其双光子吸收作用截面(δ×ΦF)在808nm处高达82GM,可在近红外激光激发下,高效地发出纯正的红光(J.P.Zhang,Y.Wang,et al.,Angew.Chem.Int.Ed.2005,44,747)。双光子吸收敏化发光途径有效地扩展了激发光的波长范围,可使激发光波长处于穿透能力较大的近红外区且对生物样品损伤或干扰很小。若将此类探针材料用于合成新型荧光生物探针,在荧光免疫分析中采用近红外激光激发,将使荧光免疫分析兼具高灵敏度、高信噪比以及大的穿透深度等优点。The inventors of the present invention once reported a rare earth complex [Eu(tta) 3 dpbt] (dpbt is shown in the structural formula II, and tta is the anion of thiophenoyltrifluoroacetone). The excitation window of this complex dissolved in toluene (dilute solution with a concentration of 10 -5 M) can be extended to 441nm, and the complex has a very high luminescence quantum yield (0.52) (Y.Wang, et al., Angew .Chem.Int.Ed.2004, 43, 5010). [Eu(tta) 3 dpbt] also has good two-photon sensitized luminescence performance, and its two-photon absorption cross section (δ×Φ F ) is as high as 82GM at 808nm, which can efficiently emit pure red light (JP Zhang, Y. Wang, et al., Angew. Chem. Int. Ed. 2005, 44, 747). The two-photon absorption-sensitized luminescence approach effectively expands the wavelength range of the excitation light, enabling the excitation light wavelength to be in the near-infrared region with greater penetrability and little damage or interference to biological samples. If such probe materials are used to synthesize new fluorescent biological probes, near-infrared laser excitation is used in fluorescence immunoassay, which will make fluorescence immunoassay have the advantages of high sensitivity, high signal-to-noise ratio and large penetration depth.
最近,Werts等报道了四种有机稀土配合物体系的双光子敏化发光性能(M.H.V.Werts,et al.,Photochem.Photobiol.Sci.2005,4,531),四者之中双光子敏化发光性能最好的Michler酮敏化的Eu(Fod)3)配合物体系在810nm激光激发下的双光子吸收作用截面(δ×ΦF)为43GM,而在840nm激光激发下,其双光子吸收作用截面低于25GM。Recently, Werts et al. reported the two-photon-sensitized luminescence properties of four organic rare earth complex systems (MHVWerts, et al., Photochem.Photobiol.Sci.2005, 4, 531), among which the two-photon-sensitized luminescence properties The best Michler ketone-sensitized Eu(Fod)3) complex system has a two-photon absorption cross section (δ×Φ F ) of 43GM under 810nm laser excitation, and its two-photon absorption cross section under 840nm laser excitation Below 25GM.
进一步向长波方向扩展稀土荧光染料的激发窗口,可以在生物成像与荧光免疫分析等方面的应用中获得更大的穿透深度,进一步减少对生物样品的损伤与干扰并且有望获得更高的检测灵敏度。Further expanding the excitation window of rare earth fluorescent dyes to the long-wave direction can obtain greater penetration depth in applications such as biological imaging and fluorescent immunoassays, further reduce damage and interference to biological samples and is expected to obtain higher detection sensitivity .
创造新型稀土配合物发光材料,使之具有宽的单光子和双光子激发窗口的同时具有大的双光子吸收作用截面和/或高稀土离子荧光量子产率具有重要的应用价值。构筑此类稀土配合物需要性能优良的光敏化配体分子。It is of great application value to create a new type of rare earth complex luminescent material, which has a wide single-photon and two-photon excitation window, a large two-photon absorption cross section and/or a high rare earth ion fluorescence quantum yield. The construction of such rare earth complexes requires photosensitizing ligand molecules with excellent properties.
(式II,dpbt) (Formula II, dpbt)
文献(Y.Wang,et al.,Angew.Chem.Int.Ed.2004,43,5010)报道的dpbt(如结构式II所示)合成方法中,中间产物N,N-二乙基胺苯基-二氯三嗪的合成方法是将N,N-二乙基苯胺与三聚氯嗪(氰脲酰氯,cyanuric chloride)直接混合、加热。由于三聚氯嗪同时进攻反应物的二乙基胺基,反应生成大量的副产物,采用这一合成方法所得中间产物N,N-二乙基胺苯基-二氯三嗪的产率低于25%。同时由于反应体系中存在大量过剩的三聚氯嗪,使产物分离困难,所以最终目标产物dpbt的产率较低,约为20%。In the synthetic method of dpbt (as shown in structural formula II) reported in literature (Y.Wang, et al., Angew.Chem.Int.Ed.2004,43,5010), the intermediate product N,N-diethylamine phenyl -The synthetic method of dichlorotriazine is that N, N-diethylaniline and tripolychlorazine (cyanuric chloride, cyanuric chloride) are directly mixed and heated. Because tripolychlorazine attacks the diethylamine group of reactant simultaneously, the reaction generates a large amount of by-products, adopts the intermediate product N of this synthetic method gained, the productive rate of N-diethylamine phenyl-dichlorotriazine is low at 25%. At the same time, because there is a large amount of excess tripolychlorazine in the reaction system, it is difficult to separate the product, so the yield of the final target product dpbt is low, about 20%.
发明内容 Contents of the invention
本发明的目的是提供具有宽激发窗口,同时具有大的双光子吸收作用截面和/或高稀土离子荧光量子产率的光敏发光铕配合物及其光敏分子配体与它们的合成方法。The object of the present invention is to provide photosensitive luminescent europium complexes and their photosensitive molecular ligands with wide excitation window, large two-photon absorption cross section and/or high rare earth ion fluorescence quantum yield and their synthesis method.
本发明所提供的光敏分子配体的结构如式I所示:The structure of the photosensitive molecular ligand provided by the present invention is shown in formula I:
(式I)(Formula I)
式I中R1、R2为碳原子数为1-4的烷基,R3=R4=R5=R6为甲基或H,R7为甲基,R8为甲基或H;所述式I中优选R1、R2为乙基,R3=R4=R5=R6=R7=R8为甲基。In formula I, R 1 and R 2 are alkyl groups with 1-4 carbon atoms, R 3 =R 4 =R 5 =R 6 is methyl or H, R 7 is methyl, R 8 is methyl or H ; In the formula I, preferably R 1 and R 2 are ethyl, and R 3 =R 4 =R 5 =R 6 =R 7 =R 8 is methyl.
本发明所提供的光敏发光铕配合物,其结构如式VI所示:The structure of the photosensitive luminescent europium complex provided by the present invention is shown in formula VI:
(式VI)(Formula VI)
式VI中R1、R2为碳原子数为1-4的烷基,R3=R4=R5=R6为甲基或H,R7为甲基,R8为甲基或H;所述式VI中优选为R1、R2为乙基,R3=R4=R5=R6=R7=R8为甲基。In formula VI, R 1 and R 2 are alkyl groups with 1-4 carbon atoms, R 3 =R 4 =R 5 =R 6 is methyl or H, R 7 is methyl, R 8 is methyl or H ; In the formula VI, R 1 and R 2 are preferably ethyl, and R 3 =R 4 =R 5 =R 6 =R 7 =R 8 is methyl.
本发明所提供的上述光敏分子配体的合成方法,包括以下步骤:The synthesis method of the above-mentioned photosensitive molecular ligand provided by the present invention comprises the following steps:
1)将对N,N-二烷基胺基-2,6-二甲基苯基锂或对N,N-二烷基胺基-2-甲基苯基锂与三聚氯嗪(氰脲酰氯,cyanuric chloride)反应,制得式IV所示的取代三嗪化合物;1) P-N, N-dialkylamino-2,6-dimethylphenyllithium or p-N, N-dialkylamino-2-methylphenyllithium and tripolychlorazine (cyanide Urea acid chloride, cyanuric chloride) reaction, makes the substituted triazine compound shown in formula IV;
2)将步骤1)获得的取代三嗪化合物与式V所示的吡唑负离子或取代吡唑负离子反应,制得式I所示的光敏有机分子配体;2) reacting the substituted triazine compound obtained in step 1) with the pyrazole anion or substituted pyrazole anion shown in formula V to prepare the photosensitive organic molecule ligand shown in formula I;
(式IV) (式V)(Formula IV) (Formula V)
其中式IV中R1、R2为碳原子数为1-4的烷基,R7为甲基,R8为甲基或H,式V中R3=R5为甲基或H。Wherein in formula IV, R 1 and R 2 are alkyl groups with 1-4 carbon atoms, R 7 is methyl, R 8 is methyl or H, and in formula V, R 3 =R 5 is methyl or H.
所述方法中,所述对N,N-二烷基胺基-2,6-二甲基苯基锂或对N,N-二烷基胺基-2-甲基苯基锂可为将式III所示化合物与烷基锂反应所制得的产物;In the method, the N, N-dialkylamino-2,6-dimethylphenyllithium or the N, N-dialkylamino-2-methylphenyllithium can be The product obtained by reacting the compound shown in formula III with alkyllithium;
(式III)(Formula III)
式III中R1、R2为碳原子数为1-4的烷基,R7为甲基,R8为甲基或H,X为I、Br、Cl等卤族元素。In formula III, R 1 and R 2 are alkyl groups with 1-4 carbon atoms, R 7 is methyl, R 8 is methyl or H, and X is halogen elements such as I, Br, and Cl.
所述方法中,所述式III所示的卤代苯胺与烷基锂反应的温度可为-78—50℃。In the method, the reaction temperature of the halogenated aniline represented by the formula III and the alkyllithium may be -78-50°C.
所述烷基锂的碳原子数为1-8。The number of carbon atoms of the alkyllithium is 1-8.
所述方法中,所述对N,N-二烷基胺基-2,6-二甲基苯基锂或对N,N-二烷基胺基-2-甲基苯基锂与三聚氯嗪反应的温度为-78—50℃。In the method, the N, N-dialkylamino-2,6-dimethylphenyllithium or the N, N-dialkylamino-2-methylphenyllithium and trimerized Chlorazine reaction temperature is -78—50°C.
所述方法中,所述步骤1)中,还包括将所述对N,N-二烷基胺基-2,6-二甲基苯基锂或对N,N-二烷基胺基-2-甲基苯基锂与三聚氯嗪反应获得的产物用过硅胶柱的方法提纯得到纯化的式IV所示的取代三嗪化合物;所述提纯用洗脱剂为二氯甲烷或氯仿。In the method, in the step 1), it also includes the p-N,N-dialkylamino-2,6-dimethylphenyllithium or the p-N,N-dialkylamino- The product obtained by the reaction of 2-methylphenyllithium and tripolychlorazine is purified by a silica gel column to obtain a purified substituted triazine compound represented by formula IV; the eluent for purification is dichloromethane or chloroform.
所述方法中,所述步骤2)中,所述式IV所示化合物与式V所示的吡唑负离子或取代吡唑负离子反应的摩尔比为1:2—10。In the method, in the step 2), the molar ratio of the compound represented by the formula IV to the pyrazole anion or substituted pyrazole anion represented by the formula V is 1:2-10.
所述方法中,所述步骤2)中,还包括将所述取代三嗪化合物与式V所示的吡唑负离子或取代吡唑负离子反应的产物进行色谱分离,然后进行重结晶,得到纯化的式I所示的光敏有机分子配体。In the method, in the step 2), it also includes chromatographically separating the product of the reaction between the substituted triazine compound and the pyrazole anion or substituted pyrazole anion shown in formula V, and then performing recrystallization to obtain purified A photosensitive organic molecule ligand shown in formula I.
本发明所提供的上述铕配合物的合成方法,是将上述制备得到的光敏有机分子配体与式XXII所示的化合物反应得到铕配合物。The method for synthesizing the above-mentioned europium complex provided by the present invention is to react the photosensitive organic molecular ligand prepared above with the compound represented by formula XXII to obtain the europium complex.
(式XXII) (Formula XXII)
所述方法中还包括将所述反应得到的铕配合物进行纯化,所述纯化方法为向配合物溶液中加入不良溶剂使配合物沉淀;所述不良溶剂选自石油醚、正己烷、环己烷中的一种或一种以上任意组合。The method also includes purifying the europium complex obtained by the reaction, the purification method is to add a poor solvent to the complex solution to precipitate the complex; the poor solvent is selected from petroleum ether, n-hexane, cyclohexane One or more than one of alkanes in any combination.
上述光敏有机分子配体和铕配合物制备方法中,所述反应可在许多有机溶剂中进行,例如四氢呋喃、乙醚、苯、甲苯、氯仿、二氯甲烷等溶剂。In the above preparation method of photosensitive organic molecular ligand and europium complex, the reaction can be carried out in many organic solvents, such as tetrahydrofuran, ether, benzene, toluene, chloroform, dichloromethane and other solvents.
本发明的光敏有机分子配体与我们最近报道的dpbt(结构如式II所示)分子存在显著结构差别。特别是式I所示化合物中R1R2N-基团的(CH2)2N-平面因苯环2,6位或2位甲基的位阻作用,与苯环平面之间存在大的夹角,当2,6位均有甲基时,此夹角接近90度,基态时N为sp3杂化;而dpbt分子中,(C2H5)N-基团的(CH2)2N-平面与苯环共平面,基态时N为sp2杂化。这一结构变化出乎意料地导致本发明的结构如式VI所示铕配合物具有更为优异的双光子敏化发光性能和更宽的可见光激发窗口。例如,当VI式中R1=R2=H3CH2C-,R3=R4=R5=R6=R7=R8=H3C-时,配合物XIV的双光子吸收作用截面高达85GM,同时其双光子激发窗口大幅度向长波方向扩展,在842nm处其双光子吸收作用截面高达56GM(见图1),双光子激发窗口尾部扩展至890nm处。而由dpbt合成的结构如式VII所示配合物的双光子吸收作用截面在波长大于810nm时明显下降,在820nm处的双光子吸收作用截面约为36GM,在波长大于850nm处几乎没有双光子敏化发光能力(见图2)。本发明的结构如式XIV的配合物是迄今长波激光双光子敏化发光性能最好的铕配合物。实验证明式VI所示新配合物具有优异的可见光敏化发光能力,其铕离子荧光量子产率大于0.4。溶解于甲苯溶液中的式VI所示新配合物(浓度为10-5M)的激发窗口能延展到450nm以上。而溶解于甲苯溶液中的式VII所示的配合物(浓度为10-5M)的激发窗口可延伸到441nm。与式VII所示配合物相比,式VI所示新配合物具有更宽的可见光激发窗口。There are significant structural differences between the photosensitive organic molecular ligand of the present invention and our recently reported dpbt (structure shown in formula II). In particular, the (CH 2 ) 2 N-plane of the R 1 R 2 N-group in the compound shown in formula I has a large distance from the plane of the benzene ring due to the steric hindrance of the 2, 6 or 2 methyl groups of the benzene ring. When both the 2 and 6 positions have methyl groups, the included angle is close to 90 degrees, and the N in the ground state is sp 3 hybridized; and in the dpbt molecule, the (C 2 H 5 )N-group (CH 2 ) The 2 N-plane is coplanar with the benzene ring, and N is sp 2 hybridized in the ground state. This structural change unexpectedly leads to the europium complex of the present invention having the structure shown in formula VI to have more excellent two-photon sensitized luminescent properties and a wider visible light excitation window. For example, when R 1 =R 2 =H 3 CH 2 C-, R 3 =R 4 =R 5 =R 6 =R 7 =R 8 =H 3 C- in Formula VI, the two-photon absorption of complex XIV The cross-section is as high as 85GM, and its two-photon excitation window is greatly extended to the long-wave direction. At 842nm, its two-photon absorption cross-section is as high as 56GM (see Figure 1), and the tail of the two-photon excitation window extends to 890nm. However, the two-photon absorption cross-section of the compound synthesized by dpbt as shown in formula VII is significantly lower when the wavelength is greater than 810nm, and the two-photon absorption cross-section at 820nm is about 36GM, and there is almost no two-photon sensitivity at wavelengths greater than 850nm. Chemiluminescent ability (see Figure 2). The complex compound with the structure of formula XIV of the present invention is the europium complex with the best long-wave laser two-photon sensitized luminescent performance so far. Experiments have proved that the new complex represented by the formula VI has excellent visible light-sensitized luminescent ability, and its europium ion fluorescence quantum yield is greater than 0.4. The excitation window of the new complex represented by formula VI dissolved in toluene solution (with a concentration of 10 −5 M) can be extended to more than 450 nm. However, the excitation window of the complex represented by formula VII dissolved in toluene solution (with a concentration of 10 −5 M) can be extended to 441 nm. Compared with the complex shown in formula VII, the new complex shown in formula VI has a wider visible light excitation window.
(式VII) (式XIV) (Formula VII) (Formula XIV)
本发明所提供的光敏分子具有优良的长波敏化发光能力,本发明所提供新型铕配合物具有很宽的激发窗口,同时具有大的双光子吸收作用截面和/或高稀土离子荧光量子产率,在生物探针合成、生物传感、成像及荧光免疫分析等方面具有重要应用价值。The photosensitive molecule provided by the present invention has excellent long-wave sensitized luminescent ability, and the novel europium complex provided by the present invention has a very wide excitation window, and at the same time has a large two-photon absorption cross section and/or high fluorescence quantum yield of rare earth ions , which has important application value in bioprobe synthesis, biosensing, imaging and fluorescence immunoassay.
本发明的合成方法在合成结构如式IV所示的关键中间产物时,以结构如式III的化合物与烷基锂反应形成的碳负离子进攻三聚氯嗪,避免了直接加热合成方法中三聚氯嗪容易进攻二烷基胺基-2,6-二甲基苯或二烷基胺基-2-甲基苯中的二烷基胺基团生成大量副产物的问题。采用本发明的合成方法,可以以高产率(大于50%)获得结构如式IV所示的关键中间产物;而若采用直接加热三聚氯嗪与二烷基胺基-2,6-二甲基苯或二烷基胺基-2-甲基苯的混合物的方法合成IV式所示的关键中间产物,则其产率小于5%。因此,采用本发明提供的合成方法可以以高产率获得所发明的结构如式II所示的新型光敏化配体分子化合物和结构如式VI所示的新型光致发光铕配合物。In the synthesis method of the present invention, when synthesizing the key intermediate product shown in formula IV, the carbanion formed by the reaction of the compound of formula III with the alkyllithium is used to attack tripolychlorazine, avoiding the trimerization in the direct heating synthesis method Chlorazine easily attacks the dialkylamine group in dialkylamino-2,6-dimethylbenzene or dialkylamino-2-methylbenzene to generate a large amount of by-products. Adopt the synthetic method of the present invention, can obtain the structure as the key intermediate product shown in formula IV with high yield (greater than 50%); The method of the mixture of base benzene or dialkylamino-2-methylbenzene synthesizes the key intermediate product shown in IV formula, then its productive rate is less than 5%. Therefore, the novel photosensitizing ligand molecular compound with the structure shown in formula II and the novel photoluminescent europium complex with the structure shown in formula VI can be obtained with high yield by using the synthesis method provided by the invention.
附图说明 Description of drawings
图1为本发明的化合物(结构如式XIV)的双光子吸收作用截面图(λem=614nm);Fig. 1 is the two-photon absorption sectional view (λ em =614nm) of the compound of the present invention (structure such as formula XIV);
图2为已报道的化合物[Eu(tta)3dpbt]双光子吸收作用截面图(λem=614nm)。Figure 2 is a cross-sectional view of the reported two-photon absorption of the compound [Eu(tta) 3 dpbt] (λ em =614nm).
具体实施方式 Detailed ways
为了更具体地说明本发明,现给出若干实施例。但本发明所涉及的内容并不仅仅局限于这些实例。下述实施例中的方法,如无特别说明,均为常规方法。在反应中所用到的原料均可以商购得到。In order to illustrate the present invention more specifically, several examples are given. However, the content involved in the present invention is not limited to these examples. The methods in the following examples are conventional methods unless otherwise specified. The raw materials used in the reaction are all commercially available.
本发明的光敏分子的合成方法,其反应过程如下所述:The synthetic method of photosensitive molecule of the present invention, its reaction process is as follows:
其中,式I、式IV、式III、式XXIII中R1、R2为碳原子数为1-4的烷基,R7为甲基,R8为甲基或H,式I、式V中R3=R4=R5=R6为甲基或H;式III中X为I、Br、Cl等卤族元素;R’Li中R’为碳原子数为1-8的烷基。Among them, in formula I, formula IV, formula III, and formula XXIII, R 1 and R 2 are alkyl groups with 1-4 carbon atoms, R 7 is methyl, R 8 is methyl or H, formula I, formula V R 3 =R 4 =R 5 =R 6 is methyl or H; in formula III, X is a halogen element such as I, Br, Cl; in R'Li, R' is an alkyl group with 1-8 carbon atoms .
本发明的有机光敏分子的合成方法,具体可包括以下步骤:The synthesis method of the organic photosensitive molecule of the present invention may specifically comprise the following steps:
1)将对N,N-二烷基胺基-2,6-二甲基苯基锂或对N,N-二烷基胺基-2-甲基苯基锂与三聚氯嗪(氰脲酰氯,cyanuric chloride)反应,制得式IV所示的取代三嗪化合物;1) P-N, N-dialkylamino-2,6-dimethylphenyllithium or p-N, N-dialkylamino-2-methylphenyllithium and tripolychlorazine (cyanide Urea acid chloride, cyanuric chloride) reaction, makes the substituted triazine compound shown in formula IV;
2)将步骤1)获得的取代三嗪化合物与式V所示的吡唑或取代吡唑负离子反应,制得式I所示的光敏化有机配体化合物;2) reacting the substituted triazine compound obtained in step 1) with the pyrazole or substituted pyrazole anion shown in formula V to prepare the photosensitized organic ligand compound shown in formula I;
本发明的铕配合物的合成方法,其反应过程如下所述The synthetic method of europium complex of the present invention, its reaction process is as follows
其中,式I、式VI中R1、R2为碳原子数为1-4的烷基,R3=R4=R5=R6为甲基或H,R7为甲基,R8为甲基或H。Among them, in formula I and formula VI, R 1 and R 2 are alkyl groups with 1-4 carbon atoms, R 3 =R 4 =R 5 =R 6 is methyl or H, R 7 is methyl, R 8 is methyl or H.
实施例1、2-(N,N-二乙基-2,6-二甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪(C25H32N8,式VIII,即式I中R1=R2=H3CH2C-,R3=R4=R5=R6=R7=R8=H3C-)光敏配体分子化合物的合成Example 1, 2-(N,N-diethyl-2,6-dimethylanilino-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl)- 1,3,5-triazine (C 25 H 32 N 8 , formula VIII, that is, in formula I, R 1 =R 2 =H 3 CH 2 C-, R 3 =R 4 =R 5 =R 6 =R 7 =R 8 =H 3 C-) Synthesis of Photosensitive Ligand Molecular Compound
取N,N-二乙基-2,6-二甲基-对溴苯胺4mmol,溶解在干燥过的四氢呋喃中,通氩气除氧,置于—78℃的干冰丙酮浴中,在氩气保护下,加入6.4mmol n-BuLi,缓慢升温至室温后,继续搅拌30min,将其加入冷冻于-78℃下的三聚氯嗪5.4mmol中,缓慢升温至室温后,继续搅拌60min。除去溶剂后,产物用硅胶柱色谱分离,洗脱剂为二氯甲烷。将所得粗产品在石油醚中重结晶,得到2-(N,N-二乙基-2,6-二甲基苯胺-4-基)-4,6-二氯-1,3,5-三嗪黄色针状晶体0.65g。在氩气保护下,将新切的金属钾1.25mmol加入到无水四氢呋喃中;加入3,5-二甲基吡唑1.75mmol,加热回流3h生成3,5-二甲基吡唑负离子;将反应混合物置于冰浴中,向其中加入2-(N,N-二乙基-2,6-二甲基苯胺-4-基)-4,6-二氯-1,3,5-三嗪0.5mmol,室温搅拌1h,然后在80-85℃的油浴中回流反应8-9h。冷却后浓缩,用二氯甲烷和乙酸乙酯的的混合液(二氯甲烷与乙酸乙酯的体积比为3:1)作洗脱剂,通过硅胶柱色谱分离。所得粗产物用石油醚和二氯甲烷的混合液(石油醚与二氯甲烷的体积比为1:1)重结晶,得到90mg的黄色针状晶体。Take 4mmol of N,N-diethyl-2,6-dimethyl-p-bromoaniline, dissolve it in dried tetrahydrofuran, pass through argon to remove oxygen, place it in a dry ice acetone bath at -78°C, and dissolve it in argon Under protection, add 6.4mmol n-BuLi, slowly warm up to room temperature, continue to stir for 30min, add it to 5.4mmol of tripolychlorazine frozen at -78°C, slowly warm up to room temperature, continue to stir for 60min. After removal of the solvent, the product was chromatographed on a silica gel column with dichloromethane as the eluent. The obtained crude product was recrystallized in petroleum ether to obtain 2-(N,N-diethyl-2,6-dimethylaniline-4-yl)-4,6-dichloro-1,3,5- Triazine yellow needle crystal 0.65g. Under the protection of argon, add 1.25 mmol of freshly cut potassium metal into anhydrous tetrahydrofuran; add 1.75 mmol of 3,5-dimethylpyrazole, heat and reflux for 3 hours to generate 3,5-dimethylpyrazole anion; The reaction mixture was placed in an ice bath, and 2-(N,N-diethyl-2,6-dimethylanilino-4-yl)-4,6-dichloro-1,3,5-tri Oxyzine 0.5mmol, stirred at room temperature for 1h, and then refluxed in an oil bath at 80-85°C for 8-9h. After cooling, concentrate, and use a mixture of dichloromethane and ethyl acetate (the volume ratio of dichloromethane to ethyl acetate is 3:1) as eluent, and separate by silica gel column chromatography. The obtained crude product was recrystallized from a mixture of petroleum ether and dichloromethane (the volume ratio of petroleum ether to dichloromethane was 1:1), and 90 mg of yellow needle-like crystals were obtained.
将所得的晶体进行质谱分析,质谱(EIMS)分析测得分子离子峰M/Z=444;元素分析值(质量百分含量):C,67.20%(67.54%);H,7.11%(7.25%);N,25.13%(25.20%),括号中为理论值。单晶X-射线分析及核磁共振谱证明产物结构如式VIII所示。The obtained crystal is subjected to mass spectrometry analysis, and mass spectrometry (EIMS) analysis records molecular ion peak M/Z=444; Elemental analysis value (mass percentage composition): C, 67.20% (67.54%); H, 7.11% (7.25% ); N, 25.13% (25.20%), the theoretical values in brackets. Single crystal X-ray analysis and nuclear magnetic resonance spectrum prove that the structure of the product is shown in formula VIII.
(式VIII) (Formula VIII)
实施例2、铕配合物[Eu(tta)3VIII](EuC49H44N8F9O6S3)的合成Example 2, Synthesis of Europium Complex [Eu(tta) 3 VIII] (EuC 49 H 44 N 8 F 9 O 6 S 3 )
在氩气保护下,将10mL Eu(tta)3·3H2O(0.03mmol)的四氢呋喃溶液滴加到10mL实施例1制备的式VIII所示的化合物(0.03mmol)的四氢呋喃溶液中,常温下搅拌30min。除去溶剂,用少量乙醚溶解过滤,用正己烷作沉淀剂析出固体并洗涤、干燥,得到27mg黄色粉末。Under argon protection, 10 mL of Eu(tta) 3 3H 2 O (0.03 mmol) in tetrahydrofuran was added dropwise to 10 mL of the compound of formula VIII (0.03 mmol) prepared in Example 1 in tetrahydrofuran. Stir for 30min. Remove the solvent, dissolve and filter with a small amount of ether, use n-hexane as a precipitant to precipitate a solid, wash it, and dry it to obtain 27 mg of a yellow powder.
将所得的黄色粉末进行质谱分析,质谱(MALDI-TOF MS)表征测得分子离子峰M/Z=1260;元素分析(质量百分含量):C,46.80%(46.71%);H,3.43%(3.52%);N,9.01%(8.89%),括号中为理论值;核磁共振谱分析表明产物为[Eu(tta)3VIII],其结构如式XIV所示。The obtained yellow powder was subjected to mass spectrometry analysis, and the mass spectrometry (MALDI-TOF MS) characterization showed that the molecular ion peak M/Z=1260; elemental analysis (mass percentage): C, 46.80% (46.71%); H, 3.43% (3.52%); N, 9.01% (8.89%), the theoretical value in brackets; NMR analysis shows that the product is [Eu(tta) 3 VIII], and its structure is shown in Formula XIV.
将配合物[Eu(tta)3VIII]溶解于甲苯中,选择已知双光子吸收截面值的RhodamineB作为标准物,按文献(J.P.Zhang,Y.Wang,et al.,Angew.Chem.Int.Ed.2005,44,747)报道的方法测定其双光子吸收作用截面,其双光子吸收作用截面如图1所示。该配合物最大双光子吸收作用截面高达85GM,在842nm处其双光子吸收作用截面高达56GM,双光子激发窗口尾部扩展至890nm处。Complex [Eu (tta) 3 VIII] is dissolved in toluene, chooses the RhodamineB of known two-photon absorption cross section value as standard substance, according to literature (JP Zhang, Y.Wang, et al., Angew.Chem.Int.Ed .2005,44,747) method to measure its two-photon absorption cross-section, and its two-photon absorption cross-section is shown in Figure 1. The maximum two-photon absorption cross section of the complex is as high as 85GM, and its two-photon absorption cross section is as high as 56GM at 842nm, and the tail of the two-photon excitation window extends to 890nm.
(式XIV) (Formula XIV)
图2为我们最近报道的[Eu(tta)3(dpbt)]配合物(Y.Wang,et al.,Angew.Chem.Int.Ed.2004,43,5010)的双光子吸收作用截面图,该配合物最大双光子吸收截面为82GM,在820nm激光激发下,其双光子吸收作用截面为36GM,而在波长大于850nm激光激发下,[Eu(tta)3(dpbt)]几乎没有双光子敏化发光能力。比较图1、图2可以发现本发明提供的[Eu(tta)3VIII]配合物具有更优异的双光子敏化发光性能。Figure 2 is the two-photon absorption cross section of our recently reported [Eu(tta) 3 (dpbt)] complex (Y.Wang, et al., Angew.Chem.Int.Ed.2004, 43, 5010), The maximum two-photon absorption cross-section of the complex is 82GM, and its two-photon absorption cross-section is 36GM under 820nm laser excitation, and [Eu(tta) 3 (dpbt)] has almost no two-photon sensitivity when excited by a laser with a wavelength greater than 850nm. luminescence ability. Comparing Fig. 1 and Fig. 2, it can be found that the [Eu(tta) 3 VIII] complex provided by the present invention has more excellent two-photon sensitized luminescence performance.
将配合物[Eu(tta)3VIII]溶解于甲苯中,以4-dicyanomethylene-2-methyl-6-p-dimethylaminostyrl-4H-pyran(DCM)的二甲亚砜溶液为参考物(Φ=0.8,J.M.Drake,et.al.,Chem.Phys.Lett.1985,113,530-534.),在波长为411nm激发光照射下,测得[Eu(tta)3VIII]的铕离子荧光量子产率为0.58(检测波长为614nm)。实验结果表明溶解于甲苯溶液中的[Eu(tta)3VIII]配合物(浓度为10-5M)的激发窗口可延展到458nm。The complex [Eu(tta) 3 VIII] was dissolved in toluene, and the dimethyl sulfoxide solution of 4-dicyanomethylene-2-methyl-6-p-dimethylaminostyrl-4H-pyran (DCM) was used as a reference (Φ=0.8 , JMDrake, et.al., Chem.Phys.Lett.1985, 113, 530-534.), under the irradiation of excitation light with a wavelength of 411nm, the europium ion fluorescence quantum yield of [Eu(tta) 3 VIII] was measured It is 0.58 (detection wavelength is 614nm). The experimental results show that the excitation window of [Eu(tta)3VIII] complex dissolved in toluene solution (concentration: 10 -5 M) can be extended to 458nm.
实施例3、2-(N,N-二甲基-2,6-二甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪(C23H28N8,式IX,即式I中R1=R2=R3=R4=R5=R6=R7=R8=H3C-)光敏配体分子化合物的合成Example 3, 2-(N,N-dimethyl-2,6-dimethylanilino-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl)- 1,3,5-triazine (C 23 H 28 N 8 , formula IX, that is, in formula I, R 1 =R 2 =R 3 =R 4 =R 5 =R 6 =R 7 =R 8 =H 3 C -) Synthesis of photosensitive ligand molecular compound
取N,N-二甲基-2,6-二甲基-对溴苯胺4mmol,溶解在干燥过的四氢呋喃中,通氩气除氧,置于—78℃的干冰丙酮浴中,在氩气保护下,加入6.4mmol乙基锂,缓慢升温至室温后,继续搅拌30min,将其加入冷冻于-78℃下的三聚氯嗪5.4mmol中,缓慢升温至室温后,继续搅拌60min。除去溶剂后,产物用硅胶柱色谱分离,洗脱剂为二氯甲烷。将所得粗产品在石油醚中重结晶,得到2-(N,N-二甲基-2,6-二甲基苯胺-4-基)-4,6-二氯-1,3,5-三嗪浅黄色针状晶体0.61g。在氩气保护下,将新切的金属钾5.0mmol加入无水四氢呋喃中;加入3,5-二甲基吡唑6.0mmol,加热回流3h生成3,5-二甲基吡唑负离子;将反应混合物置于冰浴中,向其中加入上述制备的2-(N,N-二甲基-2,6-二甲基苯胺-4-基)-4,6-二氯-1,3,5-三嗪0.5mmol,室温搅拌1h,然后在80-85℃的油浴中回流反应8-9h。冷却后浓缩,用二氯甲烷和乙酸乙酯的混合液(二氯甲烷与乙酸乙酯的体积比为2:1)作洗脱剂,通过硅胶柱色谱分离。所得粗产物用石油醚和二氯甲烷的混合液(石油醚与二氯甲烷的体积比为1:1)重结晶,得43mg的黄色针状晶体。Take 4mmol of N,N-dimethyl-2,6-dimethyl-p-bromoaniline, dissolve it in dried tetrahydrofuran, pass through argon to remove oxygen, put it in a dry ice acetone bath at -78°C, and dissolve it in argon Under protection, add 6.4 mmol of ethyllithium, slowly warm up to room temperature, continue stirring for 30 min, add it to 5.4 mmol of tripolychlorazine frozen at -78°C, slowly warm up to room temperature, and continue stirring for 60 min. After removal of the solvent, the product was chromatographed on a silica gel column with dichloromethane as the eluent. The obtained crude product was recrystallized in petroleum ether to obtain 2-(N,N-dimethyl-2,6-dimethylanilin-4-yl)-4,6-dichloro-1,3,5- Triazine pale yellow needle-like crystal 0.61g. Under the protection of argon, add 5.0 mmol of freshly cut potassium metal into anhydrous tetrahydrofuran; add 6.0 mmol of 3,5-dimethylpyrazole, heat and reflux for 3 hours to generate 3,5-dimethylpyrazole anion; The mixture was placed in an ice bath, to which was added 2-(N,N-dimethyl-2,6-dimethylanilin-4-yl)-4,6-dichloro-1,3,5 - Triazine 0.5 mmol, stirred at room temperature for 1 h, and then refluxed in an oil bath at 80-85° C. for 8-9 h. Concentrate after cooling, and use a mixture of dichloromethane and ethyl acetate (the volume ratio of dichloromethane to ethyl acetate is 2:1) as the eluent to separate by silica gel column chromatography. The obtained crude product was recrystallized with a mixture of petroleum ether and dichloromethane (the volume ratio of petroleum ether and dichloromethane was 1:1), and 43 mg of yellow needle-like crystals were obtained.
将所得的化合物进行质谱分析,质谱(EI MS)分析测得分子离子峰M/Z=416;元素分析(质量百分含量):C,66.11%(66.32%);H,6.83%(6.78%);N,26.97%(26.90%),括号中为理论值;核磁共振谱分析表明上述制备的产物结构如式IX所示。The compound of gained is carried out mass spectrum analysis, mass spectrometry (EI MS) analysis records molecular ion peak M/Z=416; Elemental analysis (mass percentage composition): C, 66.11% (66.32%); H, 6.83% (6.78% ); N, 26.97% (26.90%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product prepared above is shown in formula IX.
(式IX) (Formula IX)
实施例4、铕配合物[Eu(tta)3IX](EuC47H40N8F9O6S3)的合成Embodiment 4, synthesis of europium complex [Eu(tta) 3 IX] (EuC 47 H 4 0N 8 F 9 O 6 S 3 )
以结构如式IX所示的化合物作为配体,按照实施例2的合成方法合成得25mg配合物[Eu(tta)3IX]。25 mg of the complex [Eu(tta) 3 IX] was synthesized according to the synthesis method of Example 2, using the compound shown in Formula IX as a ligand.
质谱(MALDI-TOF MS)分析测得获得的配合物分子离子峰M/Z=1232;元素分析值(质量百分含量):C,45.70%(45.82%);H,3.30%(3.27%);N,9.14%(9.10%),括号中为理论值;核磁共振谱分析表明产物结构如式XV所示。Mass spectrometry (MALDI-TOF MS) analysis measured the complex molecular ion peak M/Z=1232; elemental analysis value (mass percentage): C, 45.70% (45.82%); H, 3.30% (3.27%) ; N, 9.14% (9.10%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula XV.
按实施例2中所述方法,以DCM的二甲亚砜溶液为参考物(Φ=0.8),在波长为411nm激发光照射下,测得式XV配合物的铕离子荧光量子产率为0.50(检测波长为614nm),荧光激发窗口拓展到455nm。According to the method described in Example 2, with the dimethyl sulfoxide solution of DCM as a reference (Φ=0.8), under the irradiation of excitation light with a wavelength of 411nm, the fluorescence quantum yield of europium ions of the complex of formula XV is measured to be 0.50 (The detection wavelength is 614nm), and the fluorescence excitation window is extended to 455nm.
(式XV) (Formula XV)
实施例5、2-(N,N-二丁基-2,6-二甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪(C29H40N8,式X,即式I中R1=R2=n-Bu,R3=R4=R5=R6=R7=R8=H3C-)光敏配体分子化合物的合成Example 5, 2-(N,N-dibutyl-2,6-dimethylanilino-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl)- 1,3,5-triazine (C 29 H 40 N 8 , formula X, that is, in formula I, R 1 =R 2 =n-Bu, R 3 =R 4 =R 5 =R 6 =R 7 =R 8 =H 3 C-) Synthesis of Photosensitive Ligand Molecular Compound
按照实施例1的合成方法,用N,N-二丁基-2,6-二甲基-对溴苯胺代替N,N-二乙基-2,6-二甲基-对溴苯胺,合成得到2-(N,N-二丁基-2,6-二甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪化合物80mg。According to the synthesis method of Example 1, replace N, N-diethyl-2,6-dimethyl-p-bromoaniline with N,N-dibutyl-2,6-dimethyl-p-bromoaniline, synthesize 2-(N,N-dibutyl-2,6-dimethylanilin-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl)-1,3 , 5-
将获得的化合物进行质谱分析,质谱(EI MS)分析测得分子离子峰M/Z=500;元素分析值(质量百分含量):C,69.45%(69.57%);H,8.14%(8.05%);N,22.49%(22.38%),括号中为理论值;核磁共振谱分析表明该产物结构如式X所示。The obtained compound is subjected to mass spectrometry analysis, and mass spectrometry (EI MS) analysis records molecular ion peak M/Z=500; Elemental analysis value (mass percentage composition): C, 69.45% (69.57%); H, 8.14% (8.05% %); N, 22.49% (22.38%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula X.
(式X) (Formula X)
实施例6、铕配合物[Eu(tta)3X](EuC53H52N8F9O6S3)的合成Example 6, Synthesis of Europium Complex [Eu(tta) 3 X] (EuC 53 H 52 N 8 F 9 O 6 S 3 )
以结构如式X所示的化合物作为配体,按照实施例2的合成方法合成得到配合物30mg。Using the compound represented by formula X as a ligand, 30 mg of the complex was synthesized according to the synthesis method of Example 2.
将获得的配合物进行质谱分析,质谱(MALDI-TOF MS)分析测得分子离子峰M/Z=1316;元素分析值(质量百分含量):C,48.40%(48.36%);H,3.91%(3.98%);N,8.55%(8.51%),括号中为理论值;核磁共振谱分析表明产物结构如式XVI所示。The obtained complex is subjected to mass spectrometry analysis, mass spectrometry (MALDI-TOF MS) analysis records molecular ion peak M/Z=1316; Elemental analysis value (mass percentage content): C, 48.40% (48.36%); H, 3.91 % (3.98%); N, 8.55% (8.51%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula XVI.
按实施例2中所述方法,以DCM的二甲亚砜溶液为参考物(Φ=0.8),在波长为411nm激发光照射下,测得式XVI配合物的铕离子荧光量子产率为0.49(检测波长为614nm),荧光激发窗口拓展到456nm。According to the method described in Example 2, taking the dimethyl sulfoxide solution of DCM as a reference (Φ=0.8), under the irradiation of excitation light with a wavelength of 411nm, the fluorescence quantum yield of europium ions of the complex of formula XVI is measured to be 0.49 (The detection wavelength is 614nm), and the fluorescence excitation window is extended to 456nm.
按实施例2的所述方法测试配合物[Eu(tta)3X]的双光子激发发光性能,其双光子吸收作用截面达75GM,在842nm处其双光子吸收作用截面高达40GM,双光子激发窗口尾部扩展至880nm处。According to the method described in Example 2, the two-photon excitation luminescence performance of the complex [Eu(tta) 3 X] was tested, and its two-photon absorption cross-section reached 75 GM, and its two-photon absorption cross-section reached 40 GM at 842 nm, and the two-photon excitation The tail of the window extends to 880nm.
(式XVI) (Formula XVI)
实施例7、2-(N,N-二乙基-2-甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪(C24H30N8,式XI,即式I中R1=R2=H3CH2C-,R3=R4=R5=R6=R7=H3C-,R8=H)光敏配体分子化合物的合成Example 7, 2-(N,N-diethyl-2-methylanilino-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl)-1,3 , 5-triazine (C 24 H 30 N 8 , formula XI, that is, in formula I, R 1 =R 2 =H 3 CH 2 C-, R 3 =R 4 =R 5 =R 6 = R 7 = H 3 C-, R 8 =H) Synthesis of Photosensitive Ligand Molecular Compound
按照实施例1的合成方法,用N,N-二乙基-2-甲基-对溴苯胺代替N,N-二乙基-2,6-二甲基-对溴苯胺,合成得到2-(N,N-二乙基-2-甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪化合物75mg。According to the synthesis method of Example 1, replace N, N-diethyl-2,6-dimethyl-p-bromoaniline with N, N-diethyl-2-methyl-p-bromoaniline, and synthesize 2- (N,N-diethyl-2-methylanilin-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl)-1,3,5-triazine compound 75mg.
将获得的化合物进行质谱分析,质谱(EI MS)分析测得该化合物分子离子峰M/Z=430;元素分析值(质量百分含量):C,66.73%(66.95%);H,7.08%(7.02%);N,26.15%(26.03%),括号中为理论值;核磁共振谱分析表明该产物结构如式XI所示。The obtained compound is subjected to mass spectrometry analysis, mass spectrometry (EI MS) analysis records this compound molecular ion peak M/Z=430; Elemental analysis value (mass percentage composition): C, 66.73% (66.95%); H, 7.08% (7.02%); N, 26.15% (26.03%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula XI.
(式XI) (Formula XI)
实施例8、铕配合物[Eu(tta)3XI](EuC48H42N8F9O6S3)的合成Example 8, Synthesis of Europium Complex [Eu(tta) 3 XI](EuC 48 H 42 N8F 9 O 6 S 3 )
在氩气保护下,将10mL Eu(tta)3·3H2O(0.03mmol)的苯溶液滴加到10mL(XI)(0.03mmol)的苯溶液中,常温下搅拌30min。除去溶剂,用少量乙醚溶解过滤,再用环己烷作沉淀剂析出固体并洗涤、干燥,得到配合物[Eu(tta)3XI]的黄色粉末27mg。Under argon protection, 10 mL of Eu(tta) 3 ·3H 2 O (0.03 mmol) in benzene was added dropwise to 10 mL of (XI) (0.03 mmol) in benzene, and stirred at room temperature for 30 min. Remove the solvent, dissolve and filter with a small amount of ether, then use cyclohexane as a precipitant to precipitate a solid, wash and dry to obtain 27 mg of a yellow powder of the complex [Eu(tta) 3 XI].
将获得的配合物进行质谱分析,质谱(MALDI-TOF MS)分析测得配合物分子离子峰M/Z=1246;元素分析值(质量百分含量):C,46.20%(46.27%);H,3.44%(3.40%);N,8.83%(8.99%),括号中为理论值;核磁共振谱分析表明产物结构如式XVII所示。The obtained complex is subjected to mass spectrometry analysis, mass spectrometry (MALDI-TOF MS) analysis records the complex molecular ion peak M/Z=1246; Elemental analysis value (mass percentage): C, 46.20% (46.27%); H , 3.44% (3.40%); N, 8.83% (8.99%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula XVII.
按实施例2的所述方法,以DCM的二甲亚砜溶液为参考物(Φ=0.8),在波长为411nm激发光照射下,测得式XVII配合物的铕离子荧光量子产率为0.51(检测波长为614nm),荧光激发窗口可拓展到455nm。According to the method described in Example 2, with the dimethyl sulfoxide solution of DCM as a reference (Φ=0.8), under the irradiation of excitation light with a wavelength of 411nm, the fluorescence quantum yield of europium ions of the complex of formula XVII is measured to be 0.51 (The detection wavelength is 614nm), and the fluorescence excitation window can be extended to 455nm.
(式XVII) (Formula XVII)
实施例9、2-(N-甲基-N-乙基-2-甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪(C23H28N8,式XII,即式I中R1=H5C2-,R2=R3=R4=R5=R6=R7=H3C-,R8=H)光敏配体分子化合物的合成Example 9, 2-(N-methyl-N-ethyl-2-methylanilin-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl)-1 , 3,5-triazine (C 23 H 2 8N 8 , formula XII, that is, in formula I, R 1 =H 5 C 2 -, R 2 =R 3 =R 4 =R 5 = R 6 = R 7 =H 3 C-, R 8 =H) Synthesis of Photosensitive Ligand Molecular Compound
按照实施例1的合成方法,用N-甲基-N-乙基-2-甲基-对溴苯胺代替N,N-二乙基-2,6-二甲基-对溴苯胺,合成得到2-(N-甲基-N-乙基-2-甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪化合物68mg。According to the synthesis method of Example 1, replace N, N-diethyl-2,6-dimethyl-p-bromoaniline with N-methyl-N-ethyl-2-methyl-p-bromoaniline, and synthesize 2-(N-methyl-N-ethyl-2-methylanilin-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl)-1,3,5 - Triazine compound 68 mg.
将获得的化合物进行质谱分析,质谱(EI MS)分析测得上述合成的化合物分子离子峰M/Z=416;元素分析值(质量百分含量):C,66.52%(66.32%);H,6.74%(6.78%);N,26.79%(26.90%),括号中为理论值;核磁共振谱分析表明产物结构如式XII所示。The obtained compound is subjected to mass spectrometry analysis, and mass spectrometry (EI MS) analysis records the above-mentioned synthetic compound molecular ion peak M/Z=416; Elemental analysis value (mass percentage composition): C, 66.52% (66.32%); H, 6.74% (6.78%); N, 26.79% (26.90%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula XII.
(式XII) (Formula XII)
实施例10、铕配合物Eu(tta)3XII(EuC47H40N8F9O6S3)的合成Example 10, Synthesis of Europium Complex Eu(tta) 3 XII (EuC 47 H 40 N 8 F 9 O 6 S 3 )
在氩气保护下,将10mL Eu(tta)3·3H2O(0.03mmol)的乙醚溶液滴加到10mL(XII)(0.03mmol)的乙醚溶液中,常温下搅拌30min。浓缩,再用石油醚作沉淀剂析出固体并洗涤、干燥,得到配合物[Eu(tta)3XII]的黄色粉末28mg。Under argon protection, 10 mL of Eu(tta) 3 ·3H 2 O (0.03 mmol) in ether was added dropwise to 10 mL of (XII) (0.03 mmol) in ether, and stirred at room temperature for 30 min. Concentrate, then use petroleum ether as a precipitating agent to precipitate a solid, wash and dry to obtain 28 mg of a yellow powder of the complex [Eu(tta) 3 XII].
将获得的配合物进行质谱分析,质谱(MALDI-TOF MS)分析测得分子离子峰M/Z=1232;元素分析值(质量百分含量):C,45.61%(45.82%);H,3.29%(3.27%);N,8.99%(9.10%),括号中为理论值;核磁共振谱分析表明产物结构如式XVIII所示。The obtained complex is subjected to mass spectrometry analysis, mass spectrometry (MALDI-TOF MS) analysis records the molecular ion peak M/Z=1232; Elemental analysis value (mass percentage content): C, 45.61% (45.82%); H, 3.29 % (3.27%); N, 8.99% (9.10%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula XVIII.
按实施例2的所述方法,以DCM的二甲亚砜溶液为参考物(Φ=0.8),在波长为411nm激发光照射下,测得式XVIII配合物的铕离子荧光量子产率为0.40(检测波长为614nm),荧光激发窗口拓展到450nm。According to the method described in Example 2, with the dimethylsulfoxide solution of DCM as a reference (Φ=0.8), under the irradiation of excitation light with a wavelength of 411nm, the fluorescence quantum yield of europium ions of the complex of formula XVIII is measured to be 0.40 (The detection wavelength is 614nm), and the fluorescence excitation window is extended to 450nm.
(式XVIII) (Formula XVIII)
实施例11、2-(N,N-二乙基-2,6-二甲基苯胺-4-基)-4,6-二(吡唑-1-基)-1,3,5-三嗪,(C21H24N8,式XIII,即式I中R1=R2=H3CH2C-,R3=R4=R5=R6=H,R7=R8=H3C-)有机光敏分子化合物的合成Example 11, 2-(N,N-diethyl-2,6-dimethylanilino-4-yl)-4,6-bis(pyrazol-1-yl)-1,3,5-tri Oxyzine, (C 21 H 24 N 8 , formula XIII, namely R 1 =R 2 =H 3 CH 2 C- in formula I, R 3 =R 4 =R 5 =R 6 =H, R 7 =R 8 = Synthesis of H 3 C-) Organic Photosensitive Molecular Compounds
按照实施例1的合成方法,用吡唑代替实施例1所述的3,5-二甲基吡唑,合成得到式XIII化合物40mg。According to the synthesis method of Example 1, pyrazole was used instead of 3,5-dimethylpyrazole described in Example 1 to obtain 40 mg of the compound of formula XIII.
将获得的化合物进行质谱分析,质谱(EI MS)分析测得分子离子峰M/Z=388;元素分析值(质量百分含量):C,64.80%(64.93%);H,6.27%(6.23%);N,28.91%(28.85%),括号中为理论值;核磁共振谱分析表明产物结构如式XIII所示。The obtained compound is subjected to mass spectrometry analysis, and mass spectrometry (EI MS) analysis records molecular ion peak M/Z=388; Elemental analysis value (mass percentage composition): C, 64.80% (64.93%); H, 6.27% (6.23% %); N, 28.91% (28.85%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula XIII.
(式XIII) (Formula XIII)
实施例12、铕配合物[Eu(tta)3XIII](EuC45H36N8F9O6S3)的合成Example 12, Synthesis of Europium Complex [Eu(tta) 3 XIII] (EuC 45 H 36 N 8 F 9 O 6 S 3 )
以结构如式XIII所示的化合物作为配体,按照实施例2的合成方法合成得到22mg配合物[Eu(tta)3XIII]。22 mg of the complex [Eu(tta) 3 XIII] was synthesized according to the synthesis method of Example 2, using the compound represented by the formula XIII as a ligand.
将获得的配合物进行质谱分析,结果表明,质谱(MALDI-TOF MS)分析测得分子离子峰M/Z=1204;元素分析值(质量百分含量):C,44.71%(44.89%);H,3.00%(3.01%);N,9.38%(9.31%),括号中为理论值;核磁共振谱分析表明产物结构如式XIX所示。The obtained complex was subjected to mass spectrometry analysis, and the results showed that the mass spectrometry (MALDI-TOF MS) analysis measured the molecular ion peak M/Z=1204; elemental analysis value (mass percentage): C, 44.71% (44.89%); H, 3.00% (3.01%); N, 9.38% (9.31%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula XIX.
(式XIX) (Formula XIX)
实施例13、2-(N-甲基-N-丁基-2,6-二甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪(C26H34N8,式XX,即式I中R1=H3C-,R2=n-H9C4-,R3=R4=R5=R6=R7=R8=H3C-)光敏配体分子化合物的合成Example 13, 2-(N-methyl-N-butyl-2,6-dimethylanilin-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl) )-1,3,5-triazine (C 26 H 34 N 8 , formula XX, that is, in formula I, R 1 =H 3 C-, R 2 =nH 9 C 4 -, R 3 =R 4 =R 5 =R 6 =R 7 =R 8 =H 3 C-) Synthesis of photosensitive ligand molecule compound
按照实施例1的合成方法,用N-甲基-N-丁基-2,6-二甲基-对碘苯胺代替N,N-二乙基-2,6-二甲基-对溴苯胺,合成得到2-(N-甲基-N-丁基-2,6-二甲基苯胺-4-基)-4,6-二(3,5-二甲基吡唑-1-基)-1,3,5-三嗪化合物39mg。According to the synthesis method of Example 1, replace N, N-diethyl-2,6-dimethyl-p-bromoaniline with N-methyl-N-butyl-2,6-dimethyl-p-iodoaniline , synthesized to obtain 2-(N-methyl-N-butyl-2,6-dimethylaniline-4-yl)-4,6-bis(3,5-dimethylpyrazol-1-yl) - 39 mg of 1,3,5-triazine compound.
将获得的化合物进行质谱分析,质谱(EI MS)分析测得分子离子峰M/Z=458;元素分析值(质量百分含量):C,67.96%(68.09%);H,7.43%(7.47%);N,24.55%(24.43%),括号中为理论值;核磁共振谱分析表明该产物结构如式XX所示。The obtained compound is subjected to mass spectrometry analysis, and mass spectrometry (EI MS) analysis records molecular ion peak M/Z=458; Elemental analysis value (mass percentage composition): C, 67.96% (68.09%); H, 7.43% (7.47 %); N, 24.55% (24.43%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the product structure is shown in formula XX.
(式XX) (Formula XX)
实施例14、铕配合物[Eu(tta)3XX](EuC50H46N8F9O6S3)的合成Example 14, Synthesis of Europium Complex [Eu(tta) 3 XX] (EuC 50 H 46 N 8 F 9 O 6 S 3 )
以结构如式XX所示的化合物作为配体,按照实施例2的合成方法合成得到配合物26mg。Using the compound of formula XX as a ligand, 26 mg of the complex was synthesized according to the synthesis method of Example 2.
将获得的配合物进行质谱分析,质谱(MALDI-TOF MS)分析测得分子离子峰M/Z=1274;元素分析值(质量百分含量):C,47.25%(47.13%);H,3.57%(3.64%);N,8.72%(8.79%),括号中为理论值;核磁共振谱分析表明产物结构如式XXI所示。The obtained complex is subjected to mass spectrometry analysis, mass spectrometry (MALDI-TOF MS) analysis records the molecular ion peak M/Z=1274; Elemental analysis value (mass percentage): C, 47.25% (47.13%); H, 3.57 % (3.64%); N, 8.72% (8.79%), the theoretical value in brackets; nuclear magnetic resonance spectrum analysis shows that the structure of the product is shown in formula XXI.
按实施例2的所述方法,以DCM的二甲亚砜溶液为参考物(Φ=0.8),在波长为411nm激发光照射下,测得式XV配合物的铕离子荧光量子产率为0.53(检测波长为614nm)。该式XV配合物的荧光激发窗口拓展到455nm。According to the method described in Example 2, with the dimethyl sulfoxide solution of DCM as a reference (Φ=0.8), under the irradiation of excitation light with a wavelength of 411nm, the fluorescence quantum yield of europium ions of the complex of formula XV is 0.53 (The detection wavelength is 614nm). The fluorescence excitation window of the compound of formula XV is extended to 455nm.
(式XXI) (Formula XXI)
图1—2的结果表明,本发明所提供的配合物XIV与已报道的铕配合物[Eu(tta)3dpbt]相比在长波方向具有更宽的双光子激发窗口。本发明所提供的式VI类配合物具有优良的可见光敏化发光能力,其铕离子荧光量子产率大于0.40,其激发窗口延展到450nm以上。The results in Figures 1-2 show that the complex XIV provided by the present invention has a wider two-photon excitation window in the long-wave direction than the reported europium complex [Eu(tta) 3 dpbt]. The type VI complex compound provided by the invention has excellent visible light-sensitized luminescent ability, its europium ion fluorescence quantum yield is greater than 0.40, and its excitation window extends above 450nm.
本发明所提供新型稀土配合物具有宽激发窗口,同时具有大的双光子吸收作用截面和/或高稀土离子荧光量子产率,可用于合成发光性能优异的生物荧光探针等功能材料。The novel rare earth complex provided by the present invention has a wide excitation window, a large two-photon absorption cross section and/or a high fluorescence quantum yield of rare earth ions, and can be used to synthesize functional materials such as bioluminescent probes with excellent luminescent properties.
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007101189788A CN100532378C (en) | 2007-06-15 | 2007-06-15 | Photosensitive luminescent europium complex and its photosensitive ligand molecule and their synthesis method |
PCT/CN2008/000945 WO2008154798A1 (en) | 2007-06-15 | 2008-05-15 | N,n-dialkylamidophenyl-dipyrazolyl triazine photosensitive compounds, their europium complexes and their preparation methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007101189788A CN100532378C (en) | 2007-06-15 | 2007-06-15 | Photosensitive luminescent europium complex and its photosensitive ligand molecule and their synthesis method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101070318A CN101070318A (en) | 2007-11-14 |
CN100532378C true CN100532378C (en) | 2009-08-26 |
Family
ID=38897748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007101189788A Expired - Fee Related CN100532378C (en) | 2007-06-15 | 2007-06-15 | Photosensitive luminescent europium complex and its photosensitive ligand molecule and their synthesis method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100532378C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008154798A1 (en) * | 2007-06-15 | 2008-12-24 | Peking University | N,n-dialkylamidophenyl-dipyrazolyl triazine photosensitive compounds, their europium complexes and their preparation methods |
CN101899038B (en) * | 2009-05-31 | 2013-07-31 | 北京大学 | Near-infrared light emitting ionic complex and preparation method thereof |
CN103804398B (en) * | 2014-01-10 | 2017-12-08 | 宁波大学 | A kind of 2 (base of 1H pyrazoles 3) pyridine copper complexes and its preparation method and application |
CN103881471B (en) * | 2014-02-12 | 2016-05-11 | 浙江大胜达包装有限公司 | A kind of preparation method of rare-earth fluorescent LOGO anti-forgery ink |
CN105973472B (en) * | 2015-03-12 | 2019-02-22 | 北京大学 | A near-infrared fluorescent temperature sensing method and material |
-
2007
- 2007-06-15 CN CNB2007101189788A patent/CN100532378C/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
A Highly Luminescent Europium Complex ShowingVisible-Light-Sentized Red Emission: Direct Observation of theSingled Pathway. Chi Yang et. al.Angew. Chem. Int. Ed.,Vol.43. 2004 * |
Efficient Two-Photon-Sensitized Luminescence ofaEuropium(III) Complex. Li-Min Fu et. al.Angew. Chem. Int. Ed.,Vol.44. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN101070318A (en) | 2007-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Dual phosphorescent dinuclear transition metal complexes, and their application as triplet photosensitizers for TTA upconversion and photodynamic therapy | |
Chow et al. | Highly luminescent palladium (II) complexes with sub-millisecond blue to green phosphorescent excited states. Photocatalysis and highly efficient PSF-OLEDs | |
Tsuchiya et al. | Thermally activated delayed fluorescence properties of trioxoazatriangulene derivatives modified with electron donating groups | |
Nayak | Synthesis, characterization and optical properties of aryl and diaryl substituted phenanthroimidazoles | |
Yu et al. | AIE-active difluoroboronated acylhydrozone dyes (BOAHY) emitting across the entire visible region and their photo-switching properties | |
Hojo et al. | Donor–acceptor materials exhibiting deep blue emission and thermally activated delayed fluorescence with tris (triazolo) triazine | |
Zhan et al. | Aggregation-induced emission and reversible mechanochromic luminescence of carbazole-based triphenylacrylonitrile derivatives | |
CN100532378C (en) | Photosensitive luminescent europium complex and its photosensitive ligand molecule and their synthesis method | |
CN101066975B (en) | Europium complex with visible light-sensitized luminescent properties and its synthesis method | |
Wang et al. | Synthesis, crystal structure, aggregation-induced emission (AIE) and electroluminescence properties of a novel emitting material based on pyrrolo [3, 2-b] pyrrole | |
Zhang et al. | Mechanofluorochromism of NIR-emitting dyes based on difluoroboron β-carbonyl cyclic ketonate complexes | |
Vuong et al. | Blue highly fluorescent boron difluoride complexes based on phthalazine–pyridine | |
Lu et al. | Synthesis and characterization of Ag (I) and Au (I) complexes with macrocyclic hybrid amine N-heterocyclic carbene ligands | |
Şenkuytu et al. | Novel fully-BODIPY functionalized cyclotetraphosphazene photosensitizers having high singlet oxygen quantum yields | |
Li et al. | Regioisomeric effects of dibenzofuran on the properties of boron–nitrogen multiple resonance emissive materials | |
CN101838476B (en) | A type of organic fluorescent dye compound and synthesis method and application thereof | |
CN101161663B (en) | Pyrazine ligand iridium complex and its synthesis method | |
Meti et al. | Facile synthesis of phenothiazine-pyrazine-based donor-acceptor-donor regioisomers: Influence of molecular geometry on aggregation-induced emission | |
Jiang et al. | A green-emitting iridium complex used for sensitizing europium ion with high quantum yield | |
CN117865950A (en) | Synthesis and application of strong D-A type organic near infrared two-region luminescent material | |
Zhang et al. | Synthesis and characterization of novel phosphorescent host materials based on triphenylpyridine derivatives | |
Xie et al. | Construction and photoswitching properties of fluorescent diarylethenes | |
CN113880886B (en) | Nickel metal complex and preparation method and application thereof | |
CN115093572B (en) | A kind of polypyridine ring metal iridium supramolecular material, preparation method and application | |
CN101081847B (en) | Synthesis method of N,N-dialkylaminophenyl-dipyrazoletriazine structure photosensitive molecule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING NACAI MATERIAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: PEKING UNIVERSITY Effective date: 20121203 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100871 HAIDIAN, BEIJING TO: 102600 DAXING, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121203 Address after: 102600, 604, building 13, building 3, Xinghua Road (two section), Xinghua Town, Daxing District, Beijing, China. Room 6 Patentee after: Beijing nano material technology Co., Ltd. Address before: 100871 Haidian District the Summer Palace Road,, No. 5, Peking University Patentee before: Peking University |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090826 Termination date: 20150615 |
|
EXPY | Termination of patent right or utility model |